RACGAP1 and breast cancer: In a follow up study, authors used breast cancer models to investigate the role of lncRNA, RACGAP1P, which acts as an endogenous competitor for a microRNA that degrades RACGAP1 (Wang et al., 2019b; Zhou et al., 2021).